[HTML][HTML] Recent advances in aptamer discovery and applications

Y Zhang, BS Lai, M Juhas - Molecules, 2019 - mdpi.com
Aptamers are short, single-stranded DNA, RNA, or synthetic XNA molecules that can be
developed with high affinity and specificity to interact with any desired targets. They have …

Therapeutic applications of AS1411 aptamer, an update review

R Yazdian-Robati, P Bayat, F Oroojalian… - International journal of …, 2020 - Elsevier
Nucleolin or C23, is one of the most abundant non-ribosomal phosphoproteins of nucleolus.
However, in several cancers, nucleolin is highly expressed both intracellularly and on the …

[HTML][HTML] Strategies for targeting gene therapy in cancer cells with tumor-specific promoters

M Montaño-Samaniego, DM Bravo-Estupiñan… - Frontiers in …, 2020 - frontiersin.org
Cancer is the second cause of death worldwide, surpassed only by cardiovascular diseases,
due to the lack of early diagnosis, and high relapse rate after conventional therapies …

G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms

PJ Bates, EM Reyes-Reyes, MT Malik… - … et Biophysica Acta (BBA …, 2017 - Elsevier
Background AS1411 is a 26-mer G-rich DNA oligonucleotide that forms a variety of G-
quadruplex structures. It was identified based on its cancer-selective antiproliferative activity …

Aptamer-modified tetrahedral DNA nanostructure for tumor-targeted drug delivery

Q Li, D Zhao, X Shao, S Lin, X Xie, M Liu… - … applied materials & …, 2017 - ACS Publications
Tetrahedral DNA nanostructures (TDNs) are considered promising drug delivery carriers
because they are able to permeate cellular membrane and are biocompatible and …

Aptamers as versatile ligands for biomedical and pharmaceutical applications

B Guan, X Zhang - International Journal of Nanomedicine, 2020 - Taylor & Francis
Aptamers are a class of targeting ligands that bind exclusively to biomarkers of interest.
Aptamers have been identified as candidates for the construction of various smart systems …

[HTML][HTML] Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy

D Liu, H Zhu, C Li - Biomarker Research, 2023 - Springer
Galectins are animal lectins with specific affinity for galactosides via the conserved
carbohydrate recognition domains. Increasing studies recently have identified critical roles …

[HTML][HTML] Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy

J Han, L Gao, J Wang, J Wang - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
Traditional anticancer therapies can cause serious side effects in clinical treatment due to
their nonspecific of tumor cells. Aptamers, also termed as' chemical antibodies', are short …

[HTML][HTML] Gemcitabine-incorporated G-quadruplex aptamer for targeted drug delivery into pancreas cancer

JY Park, YL Cho, JR Chae, SH Moon, WG Cho… - … Therapy-Nucleic Acids, 2018 - cell.com
Gemcitabine has been considered a first-line chemotherapy agent for the treatment of
pancreatic cancer. However, the initial response rate of gemcitabine is low and …

A novel AS1411 aptamer-based three-way junction pocket DNA nanostructure loaded with doxorubicin for targeting cancer cells in vitro and in vivo

SM Taghdisi, NM Danesh, M Ramezani… - Molecular …, 2018 - ACS Publications
Active targeting of nanostructures containing chemotherapeutic agents can improve cancer
treatment. Here, a three-way junction pocket DNA nanostructure was developed for efficient …